BioForward will provide personal protection equipment to Madison-area organizations that serve people with developmental disabilities and seniors, the organization announced recently. “The vulnerable people these organizations assist are at risk…
BrightStar Wisconsin Foundation announced recently that it has invested in Stem Pharm, Inc. Financial terms were not disclosed. As previously reported, the biotech company focuses on creating adult stem cell-derived neural…
Exact Sciences has acquired Paradigm Diagnostics and Viomics to extend its lab testing and research and development capabilities, the company announced recently. According to a release, Paradigm offers a comprehensive…
Stemina Biomarker Discovery announced today that its decTOX quickPredict (devTOXqP) screening platform was able to predict with high accuracy developmental toxicity in humans. The study, which published in the Toxicological Sciences, resulted from…
Promega announced recently that its custom manufacturing is being recognized for supporting the rapid development of a Utah-based company’s new coronavirus test that received CE mark approval earlier this week. According…
Stemina Biomarker Discovery’s recent study on cardiovascular toxicity was published in the Toxicological Sciences journal this month, the company announced recently. According to a release, the study suggests that the results…
Nimble Therapeutics announced recently that it will enter a multi-year collaboration with Genentech to accelerate the discovery and development of novel peptide-based medicines. According to a release, the collaboration will leverage…
JangoBio announced today that it has created organoids that emulate the production of ovarian and testicular hormones. According to a release, JangoBio’s innovation has the capacity to regenerate and replace hormone-producing…
NorthStar Medical Radioisotopes received approval from the U.S. Food and Drug Administration (FDA) the addition of two molybdenum-99 (Mo-99) filling lines at its facility in Columbia, Mo., the company announced…
Dianomi Therapeutics has licensed a second suite of intellectual property (IP) from the Wisconsin Alumni Research Foundation (WARF) to expand the use of its Mineral Coated Microparticle (MCM) technology into…
